European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

Roupret, 2018, European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update, Eur Urol, 73, 111, 10.1016/j.eururo.2017.07.036 Madigan Library at Penn College. Produced by Bob Phillips, Chris Ball, Dave Sackett, Doug Badenoch, Sharon Straus, Brian Haynes, Martin Dawes since November 1998. Updated by Jeremy Howick March 2009. Oxford Centre for evidence-based medicine: levels of evidence. May 2009. http://wwwcebmnet/indexaspx?o=1025. Siegel, 2019, Cancer statistics, 2019, CA Cancer J Clin, 69, 7, 10.3322/caac.21551 Babjuk, 2013, EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013, Eur Urol, 64, 639, 10.1016/j.eururo.2013.06.003 Cosentino, 2013, Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma, World J Urol, 31, 141, 10.1007/s00345-012-0877-2 Xylinas, 2012, Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence, Eur Urol, 61, 1069, 10.1016/j.eururo.2012.02.042 Li, 2010, Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma, Eur Urol, 57, 963, 10.1016/j.eururo.2009.12.032 Margulis, 2009, Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration, Cancer, 115, 1224, 10.1002/cncr.24135 Shariat, 2011, Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma, World J Urol, 29, 481, 10.1007/s00345-010-0594-7 Roupret, 2008, Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum, Eur Urol, 54, 1226, 10.1016/j.eururo.2008.08.008 Audenet, 2012, A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool, BJU Int, 110, E583, 10.1111/j.1464-410X.2012.11298.x Umar, 2004, Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability, J Natl Cancer Inst, 96, 261, 10.1093/jnci/djh034 Green, 2013, Urothelial carcinoma of the bladder and the upper tract: disparate twins, J Urol, 189, 1214, 10.1016/j.juro.2012.05.079 Colin, 2009, Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract, BJU Int, 104, 1436, 10.1111/j.1464-410X.2009.08838.x Chen, 2011, Arsenics and urothelial carcinoma Jelakovic, 2012, Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid, Kidney Int, 81, 559, 10.1038/ki.2011.371 Roupret, 2012, Genetic variability in 8q24 confers susceptibility to urothelial carcinoma of the upper urinary tract and is linked with patterns of disease aggressiveness at diagnosis, J Urol, 187, 424, 10.1016/j.juro.2011.10.038 Sakano, 2015, Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma, Int J Clin Oncol, 20, 362, 10.1007/s10147-014-0721-3 Ouzzane, 2011, Small cell carcinoma of the upper urinary tract (UUT-SCC): report of a rare entity and systematic review of the literature, Cancer Treat Rev, 37, 366, 10.1016/j.ctrv.2010.12.005 Rink, 2012, Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma, J Urol, 188, 398, 10.1016/j.juro.2012.04.009 Mori, 2020, Prognostic value of variant histology in upper tract urothelial carcinoma treated with nephroureterectomy: a systematic review and meta-analysis, J Urol, 203, 1075, 10.1097/JU.0000000000000523 Olgac, 2004, Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases, Am J Surg Pathol, 28, 1545, 10.1097/00000478-200412000-00001 Perez-Montiel, 2006, High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants, Mod Pathol, 19, 494, 10.1038/modpathol.3800559 Desai, 2015, Retrospective evaluation of risk factors and immunohistochemical findings for pre-neoplastic and neoplastic lesions of upper urinary tract in patients with chronic nephrolithiasis, Asian Pac J Cancer Prev, 16, 8293, 10.7314/APJCP.2015.16.18.8293 Medina Perez, 1998, [Pyelocaliceal urothelial carcinoma associated with pelvis lithiasis], Arch Esp Urol, 51, 380 Zamboni, 2019, Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy, BJU Int, 124, 738, 10.1111/bju.14751 Kim, 2017, Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma, Urol Oncol, 35, 10.1016/j.urolonc.2017.02.010 Roupret, 2015, European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update, Eur Urol, 68, 868, 10.1016/j.eururo.2015.06.044 Babjuk, 2020 Soukup, 2017, Eur Urol, 72, 801, 10.1016/j.eururo.2017.04.015 Brierley, 2016 Sauter, 2004, Tumours of the urinary system: non-invasive urothelial neoplasias Moch, 2016 Inman, 2009, Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality, Cancer, 115, 2853, 10.1002/cncr.24339 Cowan, 2012, CT urography for hematuria, Nat Rev Urol, 9, 218, 10.1038/nrurol.2012.32 Ito, 2011, Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma, J Urol, 185, 1621, 10.1016/j.juro.2010.12.035 Raman, 2011, Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?, Urol Oncol, 29, 716, 10.1016/j.urolonc.2009.11.007 Cowan, 2007, Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour, BJU Int, 99, 1363, 10.1111/j.1464-410X.2007.06766.x Janisch, 2020, Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis, World J Urol, 38, 1165, 10.1007/s00345-019-02875-8 Verhoest, 2011, Predictive factors of recurrence and survival of upper tract urothelial carcinomas, World J Urol, 29, 495, 10.1007/s00345-011-0710-3 Takahashi, 2010, Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy, J Urol, 183, 1330, 10.1016/j.juro.2009.12.031 Soria, 2017, Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC), World J Urol, 35, 379, 10.1007/s00345-016-1928-x Witjes, 2010, Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations, Eur Urol, 57, 607, 10.1016/j.eururo.2010.01.025 Rosenthal, 2016 Messer, 2011, Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma, BJU Int, 108, 701 Wang, 2009, Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria, J Urol, 181, 10.1016/j.juro.2008.10.024 Lee, 2010, MR urography versus retrograde pyelography/ureteroscopy for the exclusion of upper urinary tract malignancy, Clin Radiol, 65, 185, 10.1016/j.crad.2009.11.003 Messer, 2013, Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma, Urol Oncol, 31, 904, 10.1016/j.urolonc.2011.07.011 Malm, 2017, Diagnostic accuracy of upper tract urothelial carcinoma: how samples are collected matters, Scand J Urol, 51, 137, 10.1080/21681805.2017.1295102 Chen, 2008, Is there a role for FISH in the management and surveillance of patients with upper tract transitional-cell carcinoma?, J Endourol, 22, 1371, 10.1089/end.2008.0096 Johannes, 2010, Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance, J Urol, 184, 879, 10.1016/j.juro.2010.05.023 McHale, 2019, Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: an analysis of discordant results, Diagn Cytopathol, 47, 282, 10.1002/dc.24108 Rojas, 2013, Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma, Urol Oncol, 31, 1696, 10.1016/j.urolonc.2012.05.010 Smith, 2011, Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management, Urology, 78, 82, 10.1016/j.urology.2011.02.038 Ishikawa, 2010, Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract, J Urol, 184, 883, 10.1016/j.juro.2010.05.027 Clements, 2012, High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection, J Endourol, 26, 398, 10.1089/end.2011.0426 Brien, 2010, Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma, J Urol, 184, 69, 10.1016/j.juro.2010.03.030 Marchioni, 2017, Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis, BJU Int, 120, 313, 10.1111/bju.13935 Guo, 2018, Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis, BJU Int, 121, 184, 10.1111/bju.14053 Lee, 2018, The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence, World J Surg Oncol, 16, 135, 10.1186/s12957-018-1411-9 Bus, 2015, Optical diagnostics for upper urinary tract urothelial cancer: technology, thresholds, and clinical applications, J Endourol, 29, 113, 10.1089/end.2014.0551 Abouassaly, 2010, Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma, Urology, 76, 895, 10.1016/j.urology.2010.04.020 Kata, 2016, Photodynamic diagnostic ureterorenoscopy: a valuable tool in the detection of upper urinary tract tumour, Photodiagn Photodyn Ther, 13, 255, 10.1016/j.pdpdt.2015.08.002 Breda, 2018, Correlation between confocal laser endomicroscopy (Cellvizio((R))) and histological grading of upper tract urothelial carcinoma: a step forward for a better selection of patients suitable for conservative management, Eur Urol Focus, 4, 954, 10.1016/j.euf.2017.05.008 Bus, 2016, Optical coherence tomography as a tool for in vivo staging and grading of upper urinary tract urothelial carcinoma: a study of diagnostic accuracy, J Urol, 196, 1749, 10.1016/j.juro.2016.04.117 Jeldres, 2010, A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma, Urology, 75, 315, 10.1016/j.urology.2009.10.004 Lughezzani, 2012, Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature, Eur Urol, 62, 100, 10.1016/j.eururo.2012.02.030 Lughezzani, 2009, Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients, Eur J Cancer, 45, 3291, 10.1016/j.ejca.2009.06.016 Roupret, 2013, Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis, J Urol, 189, 1662, 10.1016/j.juro.2012.10.057 Kim, 2017, Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis, Oncotarget, 8, 7464, 10.18632/oncotarget.10708 Shariat, 2010, Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy, BJU Int, 105, 1672, 10.1111/j.1464-410X.2009.09072.x Chromecki, 2011, Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy, World J Urol, 29, 473, 10.1007/s00345-011-0677-0 Fernandez, 2009, Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study, Urology, 73, 142, 10.1016/j.urology.2008.07.042 Matsumoto, 2011, Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study, BJU Int, 108, E304, 10.1111/j.1464-410X.2011.10188.x Singla, 2017, A Multi-institutional comparison of clinicopathological characteristics and oncologic outcomes of upper tract urothelial carcinoma in China and the United States, J Urol, 197, 1208, 10.1016/j.juro.2016.11.094 Simsir, 2011, Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status, Int Urol Nephrol, 43, 1039, 10.1007/s11255-011-9915-z Rink, 2013, Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy, Eur Urol, 63, 1082, 10.1016/j.eururo.2012.06.029 Xylinas, 2014, Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy, BJU Int, 114, 56, 10.1111/bju.12400 Yafi, 2012, Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy, BJU Int, 110, E7, 10.1111/j.1464-410X.2011.10792.x Ouzzane, 2011, Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy, Eur Urol, 60, 1258, 10.1016/j.eururo.2011.05.049 Chromecki, 2012, The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy, Eur Urol, 61, 245, 10.1016/j.eururo.2011.09.017 Williams, 2013, Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma, Urol Oncol, 31, 1161, 10.1016/j.urolonc.2011.12.004 Hurel, 2015, Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy, World J Urol, 33, 335, 10.1007/s00345-014-1311-8 Isbarn, 2009, Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma, J Urol, 182, 2177, 10.1016/j.juro.2009.07.035 Sundi, 2012, Upper tract urothelial carcinoma: impact of time to surgery, Urol Oncol, 30, 266, 10.1016/j.urolonc.2010.04.002 Gadzinski, 2012, Long-term outcomes of immediate versus delayed nephroureterectomy for upper tract urothelial carcinoma, J Endourol, 26, 566, 10.1089/end.2011.0220 Lee, 2014, Impact of surgical wait time on oncologic outcomes in upper urinary tract urothelial carcinoma, J Surg Oncol, 110, 468, 10.1002/jso.23589 Waldert, 2010, A delay in radical nephroureterectomy can lead to upstaging, BJU Int, 105, 812, 10.1111/j.1464-410X.2009.08821.x Xia, 2018, Impact of surgical waiting time on survival in patients with upper tract urothelial carcinoma: a national cancer database study, Urol Oncol, 36, 10.1016/j.urolonc.2017.09.013 Berod, 2012, The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study, BJU Int, 110, E1035, 10.1111/j.1464-410X.2012.11195.x Carrion, 2016, Intraoperative prognostic factors and atypical patterns of recurrence in patients with upper urinary tract urothelial carcinoma treated with laparoscopic radical nephroureterectomy, Scand J Urol, 50, 305, 10.3109/21681805.2016.1144219 Ehdaie, 2011, Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma, J Urol, 186, 66, 10.1016/j.juro.2011.03.031 Dalpiaz, 2014, Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma, Br J Cancer, 110, 2531, 10.1038/bjc.2014.180 Vartolomei, 2018, Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients, World J Urol, 36, 1019, 10.1007/s00345-018-2235-5 Liu, 2018, The prognostic significance of preoperative serum albumin in urothelial carcinoma: a systematic review and meta-analysis, Biosci Rep, 38, 10.1042/BSR20180214 Mbeutcha, 2017, Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review, World J Urol, 35, 337, 10.1007/s00345-016-1826-2 Petrelli, 2017, Prognostic factors of overall survival in upper urinary tract carcinoma: a systematic review and meta-analysis, Urology, 100, 9, 10.1016/j.urology.2016.07.036 Fajkovic, 2012, Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma, J Urol, 187, 845, 10.1016/j.juro.2011.10.158 Roscigno, 2011, Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer, Eur Urol, 60, 776, 10.1016/j.eururo.2011.07.009 Lughezzani, 2010, A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma, Urology, 75, 118, 10.1016/j.urology.2009.07.1296 Nazzani, 2019, Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma, Eur J Surg Oncol, 45, 1238, 10.1016/j.ejso.2018.12.004 Kikuchi, 2009, Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma, J Clin Oncol, 27, 612, 10.1200/JCO.2008.17.2361 Novara, 2010, Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study, Eur Urol, 57, 1064, 10.1016/j.eururo.2009.12.029 Liu, 2019, Prognostic value of lymphovascular invasion in upper urinary tract urothelial carcinoma after radical nephroureterectomy: a systematic review and meta-analysis, Dis Markers, 2019, 10.1155/2019/7386140 Godfrey, 2012, Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion, BJU Int, 110, 798, 10.1111/j.1464-410X.2011.10893.x Samaratunga, 2019, Data set for the reporting of carcinoma of the renal pelvis and ureter-nephroureterectomy and ureterectomy specimens: recommendations from the International Collaboration on Cancer reporting (ICCR), Am J Surg Pathol, 43, e1, 10.1097/PAS.0000000000001305 Colin, 2012, Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival, Ann Surg Oncol, 19, 3613, 10.1245/s10434-012-2453-9 Zigeuner, 2010, Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract, Eur Urol, 57, 575, 10.1016/j.eururo.2009.11.035 Seitz, 2010, Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study, J Urol, 184, 1895, 10.1016/j.juro.2010.06.106 Remzi, 2009, Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients, BJU Int, 103, 307, 10.1111/j.1464-410X.2008.08003.x Fritsche, 2012, Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma, Urol Oncol, 30, 666, 10.1016/j.urolonc.2010.07.010 Wheat, 2012, Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy, Urol Oncol, 30, 252, 10.1016/j.urolonc.2010.01.001 Redrow, 2017, Upper urinary tract carcinoma in situ: current knowledge, future direction, J Urol, 197, 287, 10.1016/j.juro.2016.03.194 Roscigno, 2012, International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis, BJU Int, 110, 674, 10.1111/j.1464-410X.2012.10930.x Favaretto, 2017, Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study, World J Urol, 35, 113, 10.1007/s00345-016-1835-1 Roupret, 2005, Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma, Urology, 65, 1233, 10.1016/j.urology.2005.01.019 Soria, 2017, HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC), World J Urol, 35, 251, 10.1007/s00345-016-1871-x Bensalah, 2007, Challenges of cancer biomarker profiling, Eur Urol, 52, 1601, 10.1016/j.eururo.2007.09.036 Krabbe, 2017, Prognostic value of PD-1 and PD-L1 expression in patients with high grade upper tract urothelial carcinoma, J Urol, 198, 1253, 10.1016/j.juro.2017.06.086 Scarpini, 2012, Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract, Urol Oncol, 30, 182, 10.1016/j.urolonc.2009.12.003 Margulis, 2010, Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract, J Urol, 184, 453, 10.1016/j.juro.2010.03.142 Favaretto, 2012, Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma, BJU Int, 109, 77, 10.1111/j.1464-410X.2011.10288.x Petros, 2019, Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma, Urol Oncol, 37, 10.1016/j.urolonc.2018.12.002 Cha, 2012, Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma, Eur Urol, 61, 818, 10.1016/j.eururo.2012.01.021 Yates, 2012, Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram, Br J Cancer, 106, 1083, 10.1038/bjc.2012.64 Seisen, 2014, Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis, BJU Int, 114, 733, 10.1111/bju.12631 Ku, 2013, External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma, Br J Cancer, 109, 1130, 10.1038/bjc.2013.462 Krabbe, 2017, Postoperative nomogram for relapse-free survival in patients with high grade upper tract urothelial carcinoma, J Urol, 197, 580, 10.1016/j.juro.2016.09.078 Seisen, 2015, A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma, Eur Urol, 67, 1122, 10.1016/j.eururo.2014.11.035 Roupret, 2014, A new proposal to risk stratify urothelial carcinomas of the upper urinary tract (UTUCs) in a predefinitive treatment setting: low-risk versus high-risk UTUCs, Eur Urol, 66, 181, 10.1016/j.eururo.2013.12.007 Seisen, 2015, Risk-adapted strategy for the kidney-sparing management of upper tract tumours, Nat Rev Urol, 12, 155, 10.1038/nrurol.2015.24 Seisen, 2016, Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU Non-muscle Invasive Bladder Cancer guidelines Panel, Eur Urol, 70, 1052, 10.1016/j.eururo.2016.07.014 Cutress, 2012, Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience, BJU Int, 110, 1608, 10.1111/j.1464-410X.2012.11169.x Cutress, 2012, Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review, BJU Int, 110, 614, 10.1111/j.1464-410X.2012.11068.x Cornu, 2010, Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma, World J Urol, 28, 151, 10.1007/s00345-009-0494-x Villa, 2016, Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings, World J Urol, 34, 1201, 10.1007/s00345-015-1753-7 Vemana, 2016, Survival comparison between endoscopic and surgical management for patients with upper tract urothelial cancer: a matched propensity score analysis using Surveillance, Epidemiology and End Results-Medicare Data, Urology, 95, 115, 10.1016/j.urology.2016.05.033 Roupret, 2007, Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection, Eur Urol, 51, 10.1016/j.eururo.2006.07.019 Jeldres, 2010, Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter, J Urol, 183, 1324, 10.1016/j.juro.2009.12.018 Colin, 2012, Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study, BJU Int, 110, 1134, 10.1111/j.1464-410X.2012.10960.x Ou, 2018, Long-term outcomes of total ureterectomy with ileal-ureteral substitution treatment for ureteral cancer: a single-center experience, BMC Urol, 18, 73, 10.1186/s12894-018-0389-5 Giannarini, 2011, Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?, Eur Urol, 60, 955, 10.1016/j.eururo.2011.07.051 Irie, 2002, Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter, Urology, 59, 53, 10.1016/S0090-4295(01)01488-1 Horiguchi, 2018, Impact of bacillus Calmette-Guerin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy, Med Oncol, 35, 41, 10.1007/s12032-018-1102-y Tomisaki, 2018, Efficacy and tolerability of bacillus Calmette-Guerin therapy as the first-line therapy for upper urinary tract carcinoma in situ, Cancer Invest, 36, 152, 10.1080/07357907.2018.1430815 Yossepowitch, 2005, Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation, J Urol, 173, 890, 10.1097/01.ju.0000147747.89028.64 Foerster, 2019, Endocavitary treatment for upper tract urothelial carcinoma: a meta-analysis of the current literature, Urol Oncol, 37, 430, 10.1016/j.urolonc.2019.02.004 Roupret, 2009, Oncological risk of laparoscopic surgery in urothelial carcinomas, World J Urol, 27, 81, 10.1007/s00345-008-0349-x Ong, 2003, Trocar site recurrence after laparoscopic nephroureterectomy, J Urol, 170, 1301, 10.1097/01.ju.0000084660.73614.da Peyronnet, 2019, Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an European Association of Urology guidelines systematic review, Eur Urol Focus, 5, 205, 10.1016/j.euf.2017.10.003 Simone, 2009, Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study, Eur Urol, 56, 520, 10.1016/j.eururo.2009.06.013 Favaretto, 2010, Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?, Eur Urol, 58, 645, 10.1016/j.eururo.2010.08.005 Walton, 2011, Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort, BJU Int, 108, 406, 10.1111/j.1464-410X.2010.09826.x Ni, 2012, Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies, Eur Urol, 61, 1142, 10.1016/j.eururo.2012.02.019 Ariane, 2012, Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study, Ann Surg Oncol, 19, 301, 10.1245/s10434-011-1841-x Adibi, 2012, Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades, Int J Urol, 19, 1060, 10.1111/j.1442-2042.2012.03110.x Clements, 2018, Robotic-assisted surgery for upper tract urothelial carcinoma: a comparative survival analysis, Ann Surg Oncol, 25, 2550, 10.1245/s10434-018-6557-8 Rodriguez, 2017, Utilization and outcomes of nephroureterectomy for upper tract urothelial carcinoma by surgical approach, J Endourol, 31, 661, 10.1089/end.2017.0086 Aboumohamed, 2015, Oncologic outcomes following robot-assisted laparoscopic nephroureterectomy with bladder cuff excision for upper tract urothelial carcinoma, J Urol, 194, 1561, 10.1016/j.juro.2015.07.081 Xylinas, 2014, Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma, Eur Urol, 65, 210, 10.1016/j.eururo.2012.04.052 Xylinas, 2014, Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool, Eur Urol, 65, 650, 10.1016/j.eururo.2013.09.003 Phe, 2011, Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy?, BJU Int, 108, 130, 10.1111/j.1464-410X.2010.09835.x Kondo, 2010, Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival, Int J Urol, 17, 848, 10.1111/j.1442-2042.2010.02610.x Dominguez-Escrig, 2019, Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer, Eur Urol Focus, 5, 224, 10.1016/j.euf.2017.09.015 Dong, 2019, Lymph node dissection could bring survival benefits to patients diagnosed with clinically node-negative upper urinary tract urothelial cancer: a population-based, propensity score-matched study, Int J Clin Oncol, 24, 296, 10.1007/s10147-018-1356-6 Lenis, 2018, Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma, Urol Oncol, 36, 10.1016/j.urolonc.2017.09.001 Moschini, 2017, Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy, World J Urol, 35, 1541, 10.1007/s00345-017-2026-4 Zareba, 2017, Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract, Cancer, 123, 1741, 10.1002/cncr.30516 Xylinas, 2017, External validation of the pathological nodal staging score in upper tract urothelial carcinoma: a population-based study, Urol Oncol, 35, 10.1016/j.urolonc.2016.07.022 Xylinas, 2013, Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy, J Urol, 189, 468, 10.1016/j.juro.2012.09.036 Matin, 2015, Patterns of lymphatic metastases in upper tract urothelial carcinoma and proposed dissection templates, J Urol, 194, 1567, 10.1016/j.juro.2015.06.077 Kondo, 2014, Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: a prospective study, Int J Urol, 21, 453, 10.1111/iju.12338 Matin, 2010, Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma, Cancer, 116, 3127, 10.1002/cncr.25050 Liao, 2018, Comparison of pathological stage in patients treated with and without neoadjuvant chemotherapy for high risk upper tract urothelial carcinoma, J Urol, 200, 68, 10.1016/j.juro.2017.12.054 Meng, 2019, High response rates to neoadjuvant chemotherapy in high-grade upper tract urothelial carcinoma, Urology, 129, 146, 10.1016/j.urology.2019.01.058 Almassi, 2018, Impact of neoadjuvant chemotherapy on pathologic response in patients with upper tract urothelial carcinoma undergoing extirpative surgery, Clin Genitourin Cancer, 16, e1237, 10.1016/j.clgc.2018.08.003 Martini A., Daza J., Poltiyelova E., et al. Pathological downstaging as a novel endpoint for the development of neoadjuvant chemotherapy for upper tract urothelial carcinoma. BJU Int. In press. https://doi.org/10.1111/bju.14719. Kubota, 2017, Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study, Oncotarget, 8, 101500, 10.18632/oncotarget.21551 Hosogoe, 2018, Platinum-based neoadjuvant chemotherapy improves oncological outcomes in patients with locally advanced upper tract urothelial carcinoma, Eur Urol Focus, 4, 946, 10.1016/j.euf.2017.03.013 Porten, 2014, Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma, Cancer, 120, 1794, 10.1002/cncr.28655 Goldberg, 2018, Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis, Oncotarget, 9, 18797, 10.18632/oncotarget.24694 Necchi, 2018, BJU Int, 121, 252, 10.1111/bju.14020 Fujita, 2017, Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis, BMC Urol, 17, 110, 10.1186/s12894-017-0305-4 Seisen, 2017, Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and/or positive regional lymph node upper tract urothelial carcinoma, J Clin Oncol, 35, 852, 10.1200/JCO.2016.69.4141 Kaag, 2010, Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy, Eur Urol, 58, 581, 10.1016/j.eururo.2010.06.029 Lane, 2010, Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy, Cancer, 116, 2967, 10.1002/cncr.25043 Birtle, 2020, Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial, Lancet (London, England), 395, 1268, 10.1016/S0140-6736(20)30415-3 Hahn, 2016, Effect of adjuvant radiotherapy on survival in patients with locoregional urothelial malignancies of the upper urinary tract, Anticancer Res, 36, 4051 Huang, 2016, Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma, Sci Rep, 6, 38175, 10.1038/srep38175 Czito, 2004, Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter, J Urol, 172, 1271, 10.1097/01.ju.0000137910.38441.8a Iwata, 2019, The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: a systematic review, Urol Oncol, 37, 659, 10.1016/j.urolonc.2019.05.021 O’Brien, 2011, Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial), Eur Urol, 60, 703, 10.1016/j.eururo.2011.05.064 Ito, 2013, Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial, J Clin Oncol, 31, 1422, 10.1200/JCO.2012.45.2128 Fang, 2013, Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis, Urol Int, 91, 291, 10.1159/000350508 Dong, 2017, How do organ-specific metastases affect prognosis and surgical treatment for patients with metastatic upper tract urothelial carcinoma: first evidence from population based data, Clin Exp Metastasis, 34, 467, 10.1007/s10585-018-9884-z Seisen, 2017, Efficacy of systemic chemotherapy plus radical nephroureterectomy for metastatic upper tract urothelial carcinoma, Eur Urol, 71, 714, 10.1016/j.eururo.2016.11.012 Moschini, 2020, Efficacy of surgery in the primary tumor site for metastatic urothelial cancer: analysis of an international, multicenter, multidisciplinary database, Eur Urol Oncol, 3, 94, 10.1016/j.euo.2019.06.014 Nazzani, 2019, Survival effect of nephroureterectomy in metastatic upper urinary tract urothelial carcinoma, Clin Genitourin Cancer, 17, e602, 10.1016/j.clgc.2019.03.003 Herr, 1998, Extravesical tumor relapse in patients with superficial bladder tumors, J Clin Oncol, 16, 1099, 10.1200/JCO.1998.16.3.1099 Moschini, 2018, Impact of primary tumor location on survival from the european organization for the research and treatment of Cancer advanced urothelial Cancer studies, J Urol, 199, 1149, 10.1016/j.juro.2017.11.068 Balar, 2017, First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study, Lancet Oncol, 18, 1483, 10.1016/S1470-2045(17)30616-2 Balar, 2017, Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial, Lancet, 389, 67, 10.1016/S0140-6736(16)32455-2 Heers, 2017, Vinflunine in the treatment of upper tract urothelial carcinoma—subgroup analysis of an observational study, Anticancer Res, 37, 6437 Bellmunt, 2017, Pembrolizumab as second-line therapy for advanced urothelial carcinoma, N Engl J Med, 376, 1015, 10.1056/NEJMoa1613683 Sharma, 2017, Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial, Lancet Oncol, 18, 312, 10.1016/S1470-2045(17)30065-7 Patel, 2018, Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN solid tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial, Lancet Oncol, 19, 51, 10.1016/S1470-2045(17)30900-2 Apolo, 2017, Avelumab, an anti-programmed death-ligand 1 antibody, in patients with refractory metastatic urothelial carcinoma: results from a multicenter, phase Ib study, J Clin Oncol, 35, 2117, 10.1200/JCO.2016.71.6795 Powles, 2017, Efficacy and safety of durvalumab in locally advanced or metastatic urothelial carcinoma: updated results from a phase 1/2 open-label study, JAMA Oncol, 3, 10.1001/jamaoncol.2017.2411 Ploussard, 2015, Conditional survival after radical nephroureterectomy for upper tract carcinoma, Eur Urol, 67, 803, 10.1016/j.eururo.2014.08.003 Shigeta, 2017, The conditional survival with time of intravesical recurrence of upper tract urothelial carcinoma, J Urol, 198, 1278, 10.1016/j.juro.2017.06.073 Mandalapu, 2017, Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma, World J Urol, 35, 355, 10.1007/s00345-016-1859-6 Bagley, 2010, Ureteroscopic laser treatment of upper urinary tract neoplasms, World J Urol, 28, 143, 10.1007/s00345-010-0525-7